Akari Therapeutics (AKTX) Free Cash Flow Growth (1y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 60.84% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 88.70% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -15.72% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 66.37% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 3.98% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 137.65% |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15.72% |
| Dec 31, 2025 | -43.17% |
| Sep 30, 2025 | -42.35% |
| Jun 30, 2025 | 33.47% |
| Mar 31, 2025 | 46.83% |
| Dec 31, 2024 | 51.83% |
| Sep 30, 2024 | 39.16% |
| Jun 30, 2024 | -4.26% |
| Mar 31, 2024 | 17.13% |
| Jun 30, 2023 | 45.25% |
| Mar 31, 2023 | 3.36% |
| Jun 30, 2022 | -76.21% |
| Mar 31, 2022 | 31.93% |
| Dec 31, 2021 | 8.85% |
| Sep 30, 2021 | -8.85% |
| Jun 30, 2021 | -100.00% |
| Mar 31, 2021 | 100.00% |
| Dec 31, 2020 | 367,095,147.21% |
| Sep 30, 2020 | -258,983,854.15% |
| Jun 30, 2020 | 162,171,485.89% |
| Mar 31, 2020 | -3,380,589,239.70% |
| Dec 31, 2019 | 27.24% |
| Sep 30, 2019 | 7.89% |
| Jun 30, 2019 | 42.39% |
| Mar 31, 2019 | 105.21% |
| Dec 31, 2018 | 44.58% |
| Sep 30, 2018 | 42.14% |
| Jun 30, 2018 | -77.48% |
| Mar 31, 2018 | 52.00% |
| Dec 31, 2017 | -30.24% |
| Sep 30, 2017 | -84.33% |
| Jun 30, 2017 | 17.91% |
| Mar 31, 2017 | -23.85% |
| Dec 31, 2016 | 2.57% |
| Sep 30, 2016 | -211.31% |
| Jun 30, 2016 | -715.08% |
| Mar 31, 2016 | -272.07% |
| Dec 31, 2015 | -913.58% |
| Sep 30, 2015 | 25.90% |
| Jun 30, 2015 | 70.04% |
| Mar 31, 2015 | 2.91% |